JHJiang Han

Jiang Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jiang Han has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Pingping Hu

    Department of Hepatopancreatobiliary Surgery, The First People’s Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, China

    3 shared publications
  • Yihe Dai

    Department of Hepatobiliary Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China

    3 shared publications
  • Jia Luo

    Department of Hepatopancreatobiliary Surgery, The First People’s Hospital of Yunnan Province, the Affiliated Hospital of Kunming University of Science and Technology, Kunming, China

    2 shared publications
  • Yun Jin

    Department of Hepatobiliary Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan 650032, P.R. China

    2 shared publications
  • Haihan Song

    Central Lab, Shanghai Key Laboratory of Pathogenic Fungi Medical Testing, Shanghai Pudong New Area People’s Hospital, Shanghai, China

    1 shared publication
  • Ou Qiao

    Department of Hepatobiliary Surgery, The First People’s Hospital of Yunnan Province Kunming , No. 157, Jinbi Road, Xishan District, Kunming, Yunnan 650032

    1 shared publication

Latest Publications

  • Open Access

    Nuclear factor IA‑mediated transcriptional regulation of crystallin αB inhibits hepatocellular carcinoma progression

    by Yun Jin, Pingping Hu, Yihe Dai, Wenchao Gu, Jiang Han, Haihan Song

    Hepatocellular carcinoma (HCC) is a highly invasive malignant tumor with limited therapeutic options. In the present study, bioinformatics analysis, including differential expression analysis, functional enrichment, protein‑protein interaction network construction, survival analysis and risk model evaluation, identified CRYAB as a central prognostic gene in HCC. Additionally, motif analysis using JASPAR revealed nuclear factor IA (NFIA), as a potential transcriptional regulator of CRYAB. Further in vitro experiments were conducted to explore the roles of CRYAB and NFIA in HCC, suggesting that these molecules may serve as promising therapeutic targets for future research. Differentially expressed genes (DEGs) from the Cancer Genome Atlas‑liver hepatocellular carcinoma (LIHC) and GSE113996 datasets were identified using the ‘limma’ package, with Biological Process and Kyoto Encyclopedia of Genes and Genomes enrichment analysis conducted. Overlapping DEGs underwent Protein‑protein interaction and prognostic analysis. Key prognostic genes were selected through Kaplan‑Meier survival analysis and Least Absolute Shrinkage and Selection Operator regression before they were incorporated into a predictive risk model, which was evaluated by receiver operating characteristic analysis. JASPAR motif analysis identified NFIA as a potential transcriptional regulator of CRYAB, with the TIMER database used to further examine the NFIA expression profile among other cancers. In vitro assays using MHCC97H and Huh7 cells were used to examine the roles of CRYAB and NFIA in HCC. Cell counting kit‑8 (CCK‑8) assay was used to assess proliferation, whilst Transwell assay was used to measure migration and invasion. To investigate the reciprocal regulation, rescue experiments combining NFIA overexpression and CRYAB knockdown were performed to compare their effects on cell proliferation, migration and invasion. Additionally, dual‑luciferase assay was used to examine the regulatory effect of NFIA on the CRYAB promoter by comparing the wild‑type and mutant constructs. Bioinformatics analyses revealed CRYAB to be a hub gene. CRYAB upregulation was found to be associated with poor prognosis in patients with LIHC. In vitro, elevated CRYAB expression was observed in HCC cell lines compared with that in the huma liver immortalized cell line THLE‑2. CRYAB knockdown was found to significantly inhibit MHCC97H and Huh7 cell proliferation, migration and invasion. By contrast, NFIA expression was found to be downregulated in LIHC compared with that in normal liver tissues, where its expression showed an inverse association with that of CRYAB. Direct interaction between NFIA and the CRYAB promoter region was confirmed through dual‑luciferase assays. Furthermore, low NFIA expression markedly enhanced HCC cell proliferation, invasion and migration. This pro‑tumor effect was reversed in the si‑NFIA + si‑CRYAB group, where simultaneous downregulation of CRYAB significantly reduced cell proliferation, migration and invasion, suggesting that CRYAB downregulation can counteract the effects induced by low NFIA expression. To conclude, these results suggest that NFIA can inhibit the malignant proliferation of HCC cells by activating CRYAB expression, which further suggest that CRYAB and NFIA are promising avenues for the development of novel HCC treatment strategies.


  • Open Access

    Real-time image fusion and Apple Vision Pro in laparoscopic microwave ablation of hepatic hemangiomas

    by Tao Lan, Sichun Liu, Yihe Dai, Jia Luo, Jiang Han, Yun Jin

    Laparoscopic ultrasound-guided liver microwave ablation requires precise navigation and spatial accuracy. We developed an image fusion navigation system that integrates laparoscopic, ultrasound, and 3D liver model images into a unified real-time visualization. The Apple Vision Pro mixed reality device projects all essential image information into the surgeon’s field of view in real-time. This system reduces cognitive load and enhances surgical precision and efficiency. Comparative experiments showed a significant improvement in puncture accuracy under AVP guidance (success rate of 90%) compared to traditional methods (42.5%), benefiting both novice and experienced surgeons. According to the NASA Task Load Index evaluation, the system also reduced the workload of surgeons. In eight patients, ablation was successful with minimal blood loss, no major complications, and rapid recovery. Despite challenges such as cost and fatigue, these results highlight the potential of mixed reality technology to improve spatial navigation, reduce cognitive demands, and optimize complex surgical procedures.


  • miR-1972 inhibits hepatocellular carcinoma proliferation by targeting GZMH-mediated DNA replication in the cell cycle

    by Yun Jin, Yihe Dai, Ou Qiao, Pingping Hu, Jiang Han

    To understand the regulatory roles of miR-1972 and GZMH in hepatocellular carcinoma (HCC) and explore their potential as therapeutic biomarkers. In vitro verification of the regulation of malignant cell behavior by differential expression of miR-1972 in HCC cells. The GSE113996 dataset was studied using weighted gene co-expression network analysis (WGCNA) and differential expressed genes respectively to identify the key prognostic gene GZMH and assess the effect of its differential expression on the prognosis of the patient. Finally, the regulation of GZMH expression by miR-1972 was verified, and the effect of their combination on HCC cell behavior was analyzed. Inhibition of miR-1972 can reduce cell proliferation, migration, and invasion, while overexpression of miR-1972 has the opposite effect in HCC cells. According to the data, a positive prognosis for HCC was linked with higher GZMH expression. Interestingly, miR-1972 was observed to reverse-regulate the expression of GZMH. Besides, the combined regulation of GZMH and miR-1972 has been discovered to affect the cell growth, invasive capacity, and migratory potential of HCC cells, especially the cell cycle arrest in the G2 phase. miR-1972 regulates the malignant behavior of HCC cells, especially cell proliferation, by regulating GZMH expression.